目次

Table of Contents

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Five forces summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Type
Market segments
Comparison by Type
Adult stem cells - Market size and forecast 2020-2025
Umbilical cord blood stem cells - Market size and forecast 2020-2025
Embryonic stem cells - Market size and forecast 2020-2025
Market opportunity by Type

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Cordlife Group Ltd.
CordVida
Covis Pharma BV
Cryo Stemcell
Cryo-Cell International Inc.
Cryoviva Biotech Pvt. Ltd.
FUJIFILM Holdings Corp.
Global Cord Blood Corp.
PerkinElmer Inc.
Plus Therapeutics Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Type - Market share 2020-2025 (%)
22: Comparison by Type
23: Adult stem cells - Market size and forecast 2020-2025 ($ million)
24: Adult stem cells - Year-over-year growth 2020-2025 (%)
25: Umbilical cord blood stem cells - Market size and forecast 2020-2025 ($ million)
26: Umbilical cord blood stem cells - Year-over-year growth 2020-2025 (%)
27: Embryonic stem cells - Market size and forecast 2020-2025 ($ million)
28: Embryonic stem cells - Year-over-year growth 2020-2025 (%)
29: Market opportunity by Type
30: Customer landscape
31: Market share By Geographical Landscape 2020-2025 (%)
32: Geographic comparison
33: North America - Market size and forecast 2020-2025 ($ million)
34: North America - Year-over-year growth 2020-2025 (%)
35: Europe - Market size and forecast 2020-2025 ($ million)
36: Europe - Year-over-year growth 2020-2025 (%)
37: Asia - Market size and forecast 2020-2025 ($ million)
38: Asia - Year-over-year growth 2020-2025 (%)
39: ROW - Market size and forecast 2020-2025 ($ million)
40: ROW - Year-over-year growth 2020-2025 (%)
41: Key leading countries
42: Market opportunity By Geographical Landscape ($ million)
43: Impact of drivers and challenges
44: Vendor landscape
45: Landscape disruption
46: Industry risks
47: Vendors covered
48: Market positioning of vendors
49: Cordlife Group Ltd. - Overview
50: Cordlife Group Ltd. - Business segments
51: Cordlife Group Ltd. - Key offerings
52: Cordlife Group Ltd. - Key customers
53: Cordlife Group Ltd. - Segment focus
54: CordVida - Overview
55: CordVida - Product and service
56: CordVida - Key offerings
57: CordVida - Key customers
58: CordVida - Segment focus
59: Covis Pharma BV - Overview
60: Covis Pharma BV - Product and service
61: Covis Pharma BV - Key offerings
62: Covis Pharma BV - Key customers
63: Covis Pharma BV - Segment focus
64: Cryo Stemcell - Overview
65: Cryo Stemcell - Product and service
66: Cryo Stemcell - Key offerings
67: Cryo Stemcell - Key customers
68: Cryo Stemcell - Segment focus
69: Cryo-Cell International Inc. - Overview
70: Cryo-Cell International Inc. - Business segments
71: Cryo-Cell International Inc. - Key offerings
72: Cryo-Cell International Inc. - Key customers
73: Cryo-Cell International Inc. - Segment focus
74: Cryoviva Biotech Pvt. Ltd. - Overview
75: Cryoviva Biotech Pvt. Ltd. - Product and service
76: Cryoviva Biotech Pvt. Ltd. - Key offerings
77: Cryoviva Biotech Pvt. Ltd. - Key customers
78: Cryoviva Biotech Pvt. Ltd. - Segment focus
79: FUJIFILM Holdings Corp. - Overview
80: FUJIFILM Holdings Corp. - Business segments
81: FUJIFILM Holdings Corp. - Key offerings
82: FUJIFILM Holdings Corp. - Key customers
83: FUJIFILM Holdings Corp. - Segment focus
84: Global Cord Blood Corp. - Overview
85: Global Cord Blood Corp. - Business segments
86: Global Cord Blood Corp. - Key offerings
87: Global Cord Blood Corp. - Key customers
88: Global Cord Blood Corp. - Segment focus
89: PerkinElmer Inc. - Overview
90: PerkinElmer Inc. - Business segments
91: PerkinElmer Inc. - Key offerings
92: PerkinElmer Inc. - Key customers
93: PerkinElmer Inc. - Segment focus
94: Plus Therapeutics Inc. - Overview
95: Plus Therapeutics Inc. - Business segments
96: Plus Therapeutics Inc. - Key offerings
97: Plus Therapeutics Inc. - Key customers
98: Plus Therapeutics Inc. - Segment focus
99: Currency conversion rates for US$
100: Research Methodology
101: Validation techniques employed for market sizing
102: Information sources
103: List of abbreviations